Home » Topics » BioWorld Science

BioWorld Science
RSS

One and done: Engineered oncolytic virus can invite T cells, feed them lunch

Sep. 2, 2019

New human antibody targeting PSMA inhibits prostate cancer tumor growth

Sep. 2, 2019

Chinese investigators present adenosine A2A receptor antagonists

Sep. 2, 2019

Genifarm Laboratories and SCUT patent new compounds for cancer

Sep. 2, 2019

Novel organoid models cover a wide range of endometrial diseases

Sep. 2, 2019

Sunshine Lake Pharma discloses BIRC3 inhibitors

Sep. 2, 2019

Ancureall Biomedical Technology identifies CDK9 inhibitors

Sep. 2, 2019

MiR-125a-5p identified as tumor suppressor and biomarker in head and neck cancer

Sep. 2, 2019

Medshine Discovery divulges new KDM5A inhibitors

Sep. 2, 2019

New phase I trial to study gene therapy for APOE4 homozygotes with Alzheimer's disease

Sep. 2, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...